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Abstract
Background: Little epidemiological evaluation of recurrent seizure disorders in cats
currently exists in veterinary literature.
Objectives: To report the prevalence and risk factors for recurrent seizure disorders
(RSD) and epilepsy in cats presented to primary care veterinary practices in the
United Kingdom (UK).
Animals: A total of 285 547 cats under veterinary care during 2013 presenting to
282 primary care clinics in the UK.
Methods: Cohort study using multivariable logistic regression modeling for risk factor
analysis.
Results: There were 458 confirmed RSD cases, giving a 1-year period prevalence of
0.16% (95% confidence interval [CI], 0.15-0.18). A subset of 114 (24.89%) cases was
recorded as having epilepsy, giving a 1-year period prevalence of 0.04% (95% CI,
0.03-0.5). Increasing age was significantly associated with increasing odds of RSD.
Breed, sex, neuter status, and body weight were not associated with RSD. Epilepsy
was most frequently diagnosed in adult to middle-aged cats. Cats aged 3.0 to
<6.0 years had 3.32 times higher odds of epilepsy diagnosis compared to cats
<3.0 years of age. Insured cats were more likely to be diagnosed with epilepsy com-
pared to noninsured cats.
Conclusions and Clinical Importance: Although less common than in dogs, RSD and
epilepsy still comprise an important disorder group in the UK cat population. Aging is
a significant risk factor for these disorders in cats.
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1 | INTRODUCTION
Neurological disorders are common in cats and are among the leading
causes of mortality in the pet feline population.1,2 Of these neurologi-
cal disorders, seizures are a common reason for cats to be presented
Abbreviations: ASD, antiseizure drug; CI, confidence intervals; CSF, cerebrospinal fluid; EPR,
electronic patient record; IQR, interquartile range; MRI, magnetic resonance imaging; OR,
odds ratio; ROC, receiver operating characteristic; RSD, recurrent seizure disorders; UK,
United Kingdom.
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to a veterinary neurologist, with the prevalence of seizures in referral
populations of cats reported as 2.1% in Germany3 and 3.5% in
Austria.4 Cats with seizures represent an important and challenging
presentation for the general veterinarian, and these conditions have
the potential to cause great concern and emotional distress for owners.5
Recurrent seizure disorders (RSD) including epilepsy have been the topic
of extensive veterinary research in companion animal species over the
last 75 years, but almost exclusively based on caseloads from referral
populations and teaching hospitals. However, the reliability of generali-
zation from these secondary and tertiary care subsets to the wider cat
population has been questioned.6 Research on RSD in dogs utilizing
datasets from primary practice electronic patient records (EPR) have
reported a 1-year period prevalence for seizure occurrence in dogs of
0.82% and for suspected idiopathic epilepsy of 0.62% to 0.75%.7,8 How-
ever, to date, no similar studies have described RSD in cats.
Recurrent seizure disorders in cats represent a diagnostic challenge
for several reasons. Seizure type in cats is often atypical.9-11 Cats fre-
quently present with focal epileptic seizures,12,13 which can be mislead-
ing for both owners and practitioners and may be mistaken for other
paroxysmal events.14,15 Second, debate about the true prevalence and
clinical relevance of spontaneous genetic epilepsy in cats is ongoing.
Traditionally, genetic epilepsy was believed to be rare in cats,12,16 but a
genetic basis since has been identified in a laboratory cat colony and
now is considered an important differential diagnosis in cats.11,17,18
Confusion about diagnosis of epilepsy in both cats and dogs is
exacerbated by inconsistent use of the diagnostic terms “epilepsy” and
“idiopathic epilepsy” in the veterinary literature.16,19 The International
Veterinary Epilepsy Task Force (IVETF) addressed these issues for
dogs, but not for cats.5 Fluidity of these definitions has led some
authors to adopt the term “epilepsy of unknown cause” to describe
RSD with a clinically unremarkable diagnostic evaluation, with the aim
of maintaining a neutral stance on whether these disorders are truly
“idiopathic” or if the diagnostic techniques available in veterinary med-
icine are currently unable to elucidate the etiology.20 Although concise
definitions that can be universally agreed on undoubtedly will aid
future research efforts by use of precise terms to differentiate specific
etiologies, overzealous definitions should not detract from insight that
is currently available through more generalized use.5 Defining disor-
ders based on their phenotypic signature (eg, RSD) rather than reliance
on uncertain biomedical terms (eg, epilepsy) applied by clinicians may
offer increased reliability for research into disorder frequency.21,22
Evidence relevant to the general population of animals under pri-
mary veterinary care should be derived from the general population of
animals under primary veterinary care.23 Consequently, several large
projects are now underway that aim to merge anonymized clinical
data from primary care veterinary clinics into single databases for
research.24-27 Research using primary care veterinary clinical records
benefits from contemporaneous recording at the time of the clinical
events by veterinary professionals across the spectrum of species and
disorders recorded during their care.28 We aimed to estimate the
prevalence of RSD and epilepsy in the wider cat population under pri-
mary veterinary care in the United Kingdom (UK) and to evaluate
demographic risk factors for their occurrence. A secondary aim was to
explore risk factors associated with diagnosis of epilepsy among the
subset of cats with RSD. This information could promote understand-
ing of the clinical rationale applied by clinicians when assigning bio-
medical diagnostic terms to neurological clinical cases in cats.
2 | METHODS
The VetCompass Programme collates deidentified EPR data from
primary care veterinary practices in the UK for epidemiological
research.26 VetCompass collects information fields that include clinic
attended, species, breed, date of birth, sex, neuter status, insurance
status, body weight, and clinical information from free-form text clini-
cal notes and summary diagnosis terms (VeNom codes29), as well as
treatment and deceased status with relevant dates.
A cohort study of cats attending VetCompass practices was used to
estimate the prevalence and risk factors for RSD and epilepsy. The study
population included all cats under veterinary care within the VetCompass
database from January 1, 2013 to December 31, 2013. Recurrent seizure
disorder cases required evidence that they met the case definition during
2013. “Under veterinary care” was defined as having at least 1 EPR
recorded from January 1st to December 31st 2013 or at least one EPR
both before and after 2013. With no prior reported prevalence values
for RSD in cats available, sample size estimation was explored using both
0.25% and 0.10% expected prevalence as conservative estimates, sub-
stantially lower than the 0.82% reported in dogs in the UK.8 Sample size
calculations estimated that 38 176 cats were required to estimate the
prevalence of a disorder with a 0.25% expected prevalence and 15 321
cats were required to estimate the prevalence of a disorder with a 0.10%
to a precision of 0.05% at a 95% confidence level from a UK cat popula-
tion of 8 million cats.30,31 Ethical approval was granted by the Royal
Veterinary College Ethics and Welfare Committee (2016/BSc 20172).
Given an a priori awareness of the likely inconsistency of clinical
diagnoses applied to seizure disorders in cats,16,19 we applied a phe-
notypic signature approach to searching and assigning the RSD cases
that were included in the analysis.22 Case inclusion criteria for RSD
required that at least 1 of the following criteria applied during 2013:
at least 2 episodes of seizure events with a minimum of 24 hours
between the first and final events, a final diagnosis of epilepsy or syn-
onym (eg, epileptic) was recorded in the EPR, or was prescribed an
antiseizure drug (ASD) to manage a seizure-related disorder (based on
an assumption that ASD treatment was unlikely to be prescribed for a
solitary seizure event). Cats with only extracranial reactive seizures
(ie, seizures secondary to a primary condition external to the brain,
such as hepatic encephalopathy, electrolyte imbalances, toxicity, or
agonal seizuring) were excluded. The case definition for epilepsy
required that a final diagnosis of epilepsy or synonym (eg, epileptic)
was recorded in the EPR by the primary care veterinary team. Case
finding involved initial screening of all EPR for candidate RSD cases
using a bank of search terms including epil*, seiz*, seizure!2, had 1
fit, had 2 fits, phenob*, epiphen!2, anti-epil*, anti-convuls*, potassium
bromide, KBr, levetira*, keppra, zonisam*, 2 fits, short fit, lyrica,
pregabalin, and gabapentin. Candidate cases were randomized and
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the clinical notes of all candidates were reviewed to evaluate for case
inclusion. Additional data were extracted on confirmed cases to
describe the date of the first recorded seizure for the RSD overall, and
whether the case was diagnosed with epilepsy by the first opinion
practitioner. Confirmed RSD cases were grouped as “RSD cases” and
all remaining study cats were grouped as “noncases.”
A “purebred” variable categorized all cats of recognizable breeds as
“purebred” and the remaining cats as “crossbred.” A “breed” variable
included individual breeds that had at least 1 RSD case or that were rep-
resented by at least 1000 study animals, a grouped category of all
remaining purebreds, and a general grouping of crossbred cats. This
approach was taken to allow focus on commonly affected breeds and on
common breeds, and to facilitate statistical power for the individual
breed analyses.32 A “neuter” variable described the status of the cat
(neutered or intact) recorded at the final EPR. An “insurance” variable
described whether a cat was insured at any point during the study
period. An “age” variable categorized age (years): <3.0, 3.0-<6.0,
6.0-<9.0, 9.0-<12.0, 12.0-<15.0, ≥15.0, not recorded. Age (years) was
calculated for RSD cases at the first recorded seizure event and for non-
case cats at December 31st, 2013 (the latest date the cat was known to
be seizure-free). This approach was taken so that the age results would
reflect the odds of “becoming” a case rather than the odds of “being” a
case. An “adult body weight” variable categorized adult body weight:
<3.0 kg, 3.0-<4.0 kg, 4.0-<5.0 kg, 5.0-<6.0 kg, ≥6.0 kg, not available.
Adult body weight described the maximum body weight recorded during
the study period for cats >6 months of age. “Dominant color” defined a
categorical variable that included all colors that were recorded as com-
prising some or all of the coloration for at least 5000 study animals along
with a grouped category of all remaining less-common colors. The domi-
nant color ascribed for individual cats was determined by the first color
term used to describe the cat. “Self-color” defined a binary variable
describing whether the cat was recorded as self-colored (ie, with only a
single solid color) or not.33
After data checking and cleaning in Excel (Microsoft Office Excel
2013, Microsoft Corp.), analyses were conducted using Stata Version
13 (Stata Corporation). The 1-year period prevalence describes the
proportion of all study animals recorded with the disorder during a
specified 12-month period, which was 2013 in the current study.34
The 95% confidence interval (CI) estimates were derived from stan-
dard errors, based on approximation to the binomial distribution.35
Descriptive statistics characterized the purebred status, breed, sex,
color, neuter status, insurance, age and adult body weight for the RSD
cases and noncases. The chi squared test was used for statistical com-
parison between categorical variables.35
2.1 | Risk factors for RSD in the overall population
of cats
Binary logistic regression modeling was used to evaluate univariable
associations between risk factors (purebred, breed, adult body weight,
age, sex, neuter, insurance, dominant color, self-color), and RSD. Risk
factors with liberal associations in univariable modeling (P < .2) were
taken forward for multivariable evaluation. Model development used
manual backwards stepwise elimination. Pair-wise interaction effects
were evaluated for the final model variables. Confounding effects
TABLE 1 Prevalence of recurrent
seizure disorders (RSDs) in common cat
breeds under primary veterinary care in
the UK
Breed No. cats in study No. cases Prevalence % 95% CI
Foreign 53 1 1.89 0.05-10.07
Burmilla 119 1 0.84 0.02-4.59
Exotic 450 2 0.44 0.05-1.60
Birman 1150 5 0.43 0.14-1.01
Siberian 236 1 0.42 0.01-2.34
Burmese 1500 4 0.27 0.07-0.68
Russian 507 1 0.20 0.01-1.09
Norwegian Forest 568 1 0.18 0.00-0.98
Crossbred 252 349 417 0.17 0.15-0.18
British Short Hair 5283 8 0.15 0.07-0.30
Persian 3314 5 0.15 0.05-0.35
Bengal 3344 4 0.12 0.03-0.31
Maine Coon 1969 2 0.10 0.01-0.37
Ragdoll 2905 2 0.07 0.01-0.25
Siamese 2503 1 0.04 0.00-0.22
British Blue 1507 0 0.00 0.00-0.24
Other purebreds 3664 0 0.00 0.00-0.10
Breed not recorded 4123 3 0.07 0.02-0.21
Overall 285 547 458 0.16 0.15-0.18
Abbreviation: CI, confidence interval.
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TABLE 2 Descriptive and univariable logistic regression results for risk factors associated with diagnosis of recurrent seizure disorders (RSD)
in cats under primary veterinary care in the UK
Variable Category
Case
no. (%)
Noncase
no. (%)
Odds
ratio 95% CI
Category
P-value
Variable
P-value
Purebred status Crossbred 417 (91.1) 251 932 (88.4) Base .1
Purebred 38 (8.3) 29 034 (10.2) 0.79 0.57-1.10 .2
Unrecorded 3 (0.7) 4123 (1.5) 0.44 0.14-1.37 .2
Common breeds Crossbred 417 (91.1) 251 932 (88.4) Base .2
Bengal 4 (0.9) 3340 (1.2) 0.72 0.27-1.94 .5
Birman 5 (1.1) 1145 (0.4) 2.64 1.09-6.38 .03
British Blue 0 (0.0) 1507 (0.5) …
British Short Hair 8 (1.8) 5275 (1.9) 0.92 0.45-1.85 .8
Burmese 4 (0.9) 1496 (0.5) 1.62 0.60-4.33 .3
Burmilla 1 (0.2) 118 (0.0) 5.12 0.71-36.74 .1
Exotic 2 (0.4) 448 (0.2) 2.70 0.67-10.85 .2
Foreign 1 (0.2) 52 (0.0) 11.62 1.60-84.24 .02
Maine Coon 2 (0.4) 1967 (0.7) 0.61 0.15-2.47 .5
Norwegian Forest 1 (0.2) 567 (0.2) 1.07 0.15-7.60 1
Other purebreds 0 (0.00) 3664 (1.3) …
Persian 5 (1.1) 3309 (1.2) 0.91 0.38-2.21 .8
Ragdoll 2 (0.4) 2903 (1.0) 0.42 0.10-1.67 .2
Russian 1 (0.2) 506 (0.2) 1.19 0.17-8.51 .9
Siamese 1 (0.2) 2502 (0.9) 0.24 0.03-1.72 .2
Siberian 1 (0.2) 235 (0.1) 2.57 0.36-18.37 .4
Unrecorded 3 (0.7) 4123 (1.5) 0.44 0.14-1.37 .2
Self-color Single 235 (51.3) 137 752 (48.3) Base .08
Multiple 213 (46.5) 136 251 (47.8) 0.92 0.76-1.10 .4
Unrecorded 10 (2.2) 11 082 (3.9) 0.53 0.28-1.00 .05
Dominant color Black 182 (39.7) 108 551 (38.1) Base .43
Tabby 94 (20.5) 52 152 (18.3) 1.08 0.84-1.38 .6
Ginger 35 (7.6) 25 902 (9.1) 0.81 0.56-1.16 .24
Tortoiseshell 40 (8.7) 24 508 (8.6) 0.97 0.69-1.37 .9
Gray 24 (5.2) 16 182 (5.7) 0.88 0.58-1.35 .6
White 28 (6.1) 15 357 (5.4) 1.09 0.73-1.62 .7
Blue 10 (2.2) 6219 (2.2) 0.96 0.51-1.82 .9
Other color 35 (7.6) 25 132 (8.8) 0.83 0.58-1.19 .32
Unrecorded 10 (2.2) 11 086 (3.9) 0.54 0.28-1.02 .06
Age category (years) <3.0 97 (21.2) 105 557 (37.0) Base <.001
3.0-<6.0 66 (14.4) 59 813 (21.0) 1.20 0.88-1.64 .2
6.0-<9.0 65 (14.2) 38 117 (13.4) 1.86 1.36-2.54 <.001
9.0-<12.0 63 (13.8) 26 999 (9.5) 2.54 1.85-3.49 <.001
12.0-<15.0 64 (14.0) 22 536 (7.9) 3.09 2.25-4.24 <.001
≥15.0 97 (21.2) 22 239 (7.8) 4.75 3.58-6.29 <.001
Unrecorded 6 (1.3) 9808 (3.4) 0.67 0.29-1.52 .33
Adult body weight (kg)
(>6 months)
<3.0 16 (3.5) 13 023 (4.6) Base .0008
3.0-<4.0 59 (12.9) 43 179 (15.2) 1.11 0.64-1.93 .71
4.0-<5.0 68 (14.9) 53 374 (18.7) 1.04 0.60-1.79 .9
5.0-<6.0 36 (7.9) 31 580 (11.1) 0.93 0.51-1.67 .803
≥6.0 34 (7.4) 16 660 (5.8) 1.66 0.92-3.01 .09
Unrecorded 245 (53.5) 127 273 (44.6) 1.57 0.94-2.60 .08
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from dropped variables were assessed by individual reintroduction to
the final model. The likelihood ratio test was used to compare a ran-
dom effects model with clinic entered as a random effect against the
nonrandom effects model with P < .05 cut-off used for selection of
the random effects model. The Hosmer-Lemeshow test statistic36 and
the area under the receiver operating characteristic (ROC) curve were
used to evaluate model fit.34 Statistical significance was set at P < .05.
2.2 | Risk factors for epilepsy in the overall
population of cats
These methods were repeated to evaluate risk factors associated with
epilepsy in the overall population after dropping RSD cases that were
not classified as epilepsy.
2.3 | Risk factors for epilepsy among cats
with RSD
These methods also were applied to explore risk factors associated
with diagnosis of epilepsy among the subset of cats that were
recorded with RSD.
3 | RESULTS
The study population consisted of 285 547 cats under veterinary care
during 2013 attending 282 primary care clinics in the UK. There were
1497 cats identified as candidate RSD cases. All candidate cases were
checked to confirm 458 (30.59% of the candidates) as RSD cases, giving
an overall 1-year period prevalence for RSD in cats in the UK of 0.16%
(95% CI, 0.15-0.18). Breeds with the highest RSD prevalence were For-
eign (1.89% of the breed affected; 95% CI, 0.05-10.07) and Burmilla
(0.84%; 95% CI, 0.02-4.59). The prevalence of RSD did not differ
between crossbred cats (0.17%; 95% CI, 0.15-0.18) and purebred cats
(0.13%; 95% CI, 0.09-0.18, P = .165; Table 1).
Of the 458 RSD cases, 114 (24.89%) were recorded with epilepsy
by the first opinion veterinary practitioners, giving an overall 1-year
period prevalence for first opinion-classified epilepsy in cats in the UK
of 0.04% (95% CI, 0.03-0.05). In addition, the possibility of epilepsy
was discussed in the clinical records of an additional 69 RSD cases
without confirmation recorded in the notes.
Of the RSD cases with complete data available for that variable,
38/455 (8.4%) were purebred, 240/456 (52.6%) were female,
285/324 (88.0%) were neutered, 88/161 (54.7%) were insured, and
235/448 (52.5%) were self-colored. The most common colors of RSD
cases (color information available on 448 cats) were black (n = 182,
40.6%) and tabby (n = 94, 21.0%; Table 2). The median adult body
weight for RSD cats was 4.4 kg (interquartile range [IQR], 3.6-5.5;
range, 2.2-9.6). The median age at first recorded seizure event for
RSD cases overall was 8.9 years (IQR, 3.5-14.2; range, 0.2-25.1). The
median age at the first recorded seizure event for the subset of RSD
cases recorded with epilepsy was 6.4 years (IQR, 3.5-11.3; range,
0.2-18.0) (Figure 1).
TABLE 2 (Continued)
Variable Category
Case
no. (%)
Noncase
no. (%)
Odds
ratio 95% CI
Category
P-value
Variable
P-value
Sex Female 240 (52.4) 145 668 (51.1) Base .5
Male 216 (47.2) 136 860 (48.0) 0.96 0.80-1.15 .7
Unrecorded 2 (0.4) 2561 (0.9) 0.47 0.12-1.91 .3
Neuter status Entire 39 (8.5) 40 927 (14.4) Base <.001
Neutered 285 (62.2) 183 783 (64.5) 1.63 1.16-2.27 .004
Unrecorded 134 (29.3) 60 379 (21.2) 2.33 1.63-3.33 <.001
Insurance Noninsured 73 (15.9) 28 652 (10.1) Base <.001
Insured 88 (19.2) 26 636 (9.3) 1.30 0.95-1.77 .1
Unrecorded 297 (64.9) 229 801 (80.6) 0.51 0.39-0.66 <.001
Notes: Column percentages shown in brackets. N = 285 547.
Abbreviation: CI, confidence interval.
F IGURE 1 Age (years) at the first recorded seizure event for cats
under primary veterinary care in the UK diagnosed with recurrent
seizure disorders (RSD) (N = 458) and epilepsy (N = 114)
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TABLE 3 Final multivariable logistic regression model for risk factors associated with diagnosis of recurrent seizure disorders (RSDs) in cats
under primary veterinary care in the UK
Variable Category Odds ratio 95% CI
Category
P-value
Variable
P-value
Age category (years) <3.0 Base <.001
3.0-<6.0 1.08 0.79-1.48 .64
6.0-<9.0 1.64 1.20-2.26 .002
9.0-<12.0 2.23 1.62-3.07 <.001
12.0-<15.0 2.72 1.98-3.75 <.001
≥15.0 4.27 3.21-5.69 <.001
Unrecorded 0.71 0.31-1.61 .41
Insurance Noninsured Base <.001
Insured 1.49 1.09-2.04 .012
Unrecorded 0.66 0.51-0.86 .002
Notes: N = 285 547.
Abbreviation: CI, confidence interval.
TABLE 4 Descriptive and univariable logistic regression results for risk factors associated with diagnosis of epilepsy by primary care
practitioners in cats under primary veterinary care in the UK
Variable Category Case no. (%) Noncase no. (%) Odds ratio 95% CI
Category
P-value
Variable
P-value
Purebred status Crossbred 103 (90.4) 251 932 (88.4) Base .81
Purebred 11 (9.6) 29 034 (10.2) 0.93 0.50-1.73 .81
Unrecorded 0 (0.0) 4123 (1.5) …
Common breeds Crossbred 103 (90.4) 251 932 (88.4) Base .2
Bengal 1 (0.9) 3340 (1.2) 0.73 0.10-5.25 .8
Birman 1 (0.9) 1145 (0.4) 2.14 0.30-15.32 .5
British Blue 0 (0.0) 1507 (0.5) …
British Short
Hair
4 (3.5) 5275 (1.9) 1.85 0.68-5.04 .23
Burmese 2 (1.8) 1496 (0.5) 3.27 0.81-13.26 .1
Burmilla 0 (0.0) 118 (0.0) …
Exotic 2 (1.8) 448 (0.2) 10.92 2.69-44.38 .001
Foreign 0 (0.0) 52 (0.0) …
Maine Coon 0 (0.0) 1967 (0.7) …
Norwegian
Forest
0 (0.0) 567 (0.2) …
Other purebreds 0 (0.0) 3664 (1.3) …
Persian 0 (0.0) 3309 (1.2) …
Ragdoll 0 (0.0) 2903 (1.0) …
Russian 0 (0.0) 506 (0.2) …
Siamese 1 (0.9) 2502 (0.9) 0.98 0.14-7.01 1
Siberian 0 (0.0) 235 (0.1) …
Unrecorded 0 (0.0) 4123 (1.5) …
Self-color Single 55 (48.3) 137 752 (48.3) Base .41
Multiple 57 (50.0) 136 251 (47.8) 1.05 0.72-1.52 .81
Unrecorded 2 (1.7) 11 082 (3.9) 0.45 0.11-1.85 .27
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Of the noncase cats with complete data, 29 034/280 966
(10.3%) were purebred, 145 668/282 528 (51.6%) were female,
183 783/224 710 (81.8%) were neutered, 26 636/55 288 (48.2%)
were insured and 137 752/274 003 (50.3%) were self-colored. The
most common colors of noncase cats (color information available on
274 003 cats) were black (n = 108 551; 39.6%) and tabby
(n = 52 152; 19.0%). The median adult body weight for noncase cats
was 4.4 kg (IQR, 3.7-5.2; range: 1.0-19.8). The median age for non-
case cats on December 31, 2013 was 4.4 years (IQR, 1.7-9.3; range,
0.0-28.7; Table 2). Data completeness varied for the variables
assessed: sex, 99.1%; breed, 98.6%; age, 96.6%; color, 96.1%; neu-
ter status; 78.8%, body weight; 59.6%, insurance; 19.4%.
3.1 | Risk factors for RSD in the overall population
of cats
Univariable logistic regression modeling identified 7 variables liberally
associated with RSD that were further evaluated in multivariable logistic
regression modeling: purebred, breed, self-color, age, adult body weight,
neuter status and insurance. The final multivariable model retained 2 risk
factors: age, and insurance. No biologically significant interactions were
identified in the final model. The final model was not improved by inclu-
sion of the clinic attended as a random effect (rho, 0.008; P = .26). The
final model showed acceptable model fit (Hosmer-Lemeshow test statis-
tic, P = .14) and discrimination (area under the ROC curve, 0.681).
TABLE 4 (Continued)
Variable Category Case no. (%) Noncase no. (%) Odds ratio 95% CI
Category
P-value
Variable
P-value
Dominant color Black 53 (46.5) 108 551 (38.1) Base .34
Tabby 19 (16.7) 52 152 (18.3) 0.75 0.44-1.26 .3
Ginger 9 (7.9) 25 902 (9.1) 0.71 0.35-1.44 .4
Tortoiseshell 11 (9.7) 24 508 (8.6) 0.92 0.48-1.76 .8
Gray 2 (1.8) 16 182 (5.7) 0.25 0.06-1.04 .1
White 7 (6.1) 15 357 (5.4) 0.93 0.42-2.05 .9
Blue 3 (2.6) 6219 (2.2) 0.99 0.31-3.16 1
Other color 8 (7.0) 25 132 (8.8) 0.65 0.31-1.37 .3
Unrecorded 2 (1.8) 11 086 (3.9) 0.37 0.09-1.52 .2
Age category (years) <3.0 21 (18.4) 105 557 (37.0) Base .001
3.0-<6.0 31 (27.2) 59 813 (21.0) 2.61 1.50-4.53 .001
6.0-<9.0 19 (16.7) 38 117 (13.4) 2.51 1.35-4.66 .004
9.0-<12.0 17 (14.9) 26 999 (9.5) 3.17 1.67-6.00 <.001
12.0-<15.0 9 (7.9) 22 536 (7.9) 2.01 0.92-4.38 .1
≥15.0 14 (12.3) 22 239 (7.8) 3.16 1.61-6.22 .001
Unrecorded 3 (2.6) 9808 (3.4) 1.54 0.46-5.16 .5
Adult body weight (kg)
(>6 months)
<3.0 1 (0.9) 13 023 (4.6) 0.26 0.03-1.95 .2 .02
3.0-<4.0 13 (11.4) 43 179 (15.2) Base
4.0-<5.0 13 (11.4) 53 374 (18.7) 0.81 0.37-1.75 .6
5.0-<6.0 15 (13.2) 31 580 (11.1) 1.58 0.75-3.32 .23
≥6.0 9 (7.9) 16 660 (5.8) 1.79 0.77-4.20 .2
Unrecorded 63 (55.3) 127 273 (44.6) 1.64 0.90-2.99 .103
Sex Female 62 (54.4) 145 668 (51.1) Base .8
Male 51 (44.7) 136 860 (48.0) 0.88 0.60-1.27 .5
Unrecorded 1 (0.9) 2561 (0.9) 0.92 0.13-6.62 .93
Neuter status Entire 6 (5.3) 40 927 (14.4) Base .001
Neutered 72 (63.2) 183 783 (64.5) 2.67 1.16-6.15 .021
Unrecorded 36 (31.6) 60 379 (21.2) 4.07 1.71-9.65 .001
Insurance Noninsured 16 (14.0) 28 652 (10.1) Base <.001
Insured 34 (29.8) 26 636 (9.3) 2.29 1.26-4.14 .006
Unrecorded 64 (56.1) 229 801 (80.6) 0.49 0.29-0.86 .01
Notes: Column percentages shown in brackets. N = 285 203.
Abbreviation: CI, confidence interval.
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The odds of RSD increased progressively as cats aged. Compared with
cats aged <3.0 years, cats aged 9.0 to <12.0 years had 2.23 times the
odds (95% CI, 1.62-3.07; P < .001) and cats aged >15.0 years had 4.27
times the odds (95% CI, 3.21-5.69; P < .001). Insured cats had 1.49
(95% CI, 1.09-2.04; P = .01) times the odds of RSD compared with
uninsured cats (Table 3).
3.2 | Risk factors for epilepsy in the overall
population of cats
Univariable logistic regression modeling identified 5 variables that
were liberally associated with epilepsy and were further evaluated in
multivariable logistic regression modeling: breed, age, adult body
weight, neuter status and insurance (Table 4). The final multivariable
model retained 2 risk factors: age, and insurance. No biologically sig-
nificant interactions were identified in the final model. The final model
was not improved by inclusion of the clinic attended as a random
effect (rho, 0.008; P < .44). The final model showed acceptable model
fit (Hosmer-Lemeshow test statistic, P = .16) and discrimination (area
under the ROC curve, 0.700). Compared with cats aged <3.0 years,
the odds of epilepsy were higher in all older age groups except for
cats aged 12.0 to <15.0 years. Insured cats had 2.38 (95% CI, 1.31-
4.33; P = .004) times the odds of epilepsy compared with uninsured
cats (Table 5).
3.3 | Risk factors for epilepsy among cats
with RSD
Multivariable logistic regression modeling identified age as the only
factor associated with classification of epilepsy (114 epilepsy cases)
among the subset of 458 cats with RSD. Cats aged 3.0 to <6.0 years
had 3.32 (95% CI, 1.66-6.67; P = .001) times the odds of RSD
TABLE 5 Final multivariable logistic regression model for risk factors associated with diagnosis of epilepsy by primary-care practitioners in
cats under primary veterinary care in the UK
Variable Category Odds ratio 95% CI Category P-value Variable P-value
Age category (years) <3.0 Base .04
3.0-<6.0 2.15 1.22-3.76 .008
6.0-<9.0 2.01 1.07-3.76 .03
9.0-<12.0 2.50 1.31-4.79 .006
12.0-<15.0 1.61 0.73-3.55 .234
≥15.0 2.69 1.36-5.34 .005
Unrecorded 1.74 0.52-5.85 .4
Insurance Noninsured Base <.001
Insured 2.38 1.31-4.33 .004
Unrecorded 0.59 0.34-1.04 .07
Notes: N = 285 203.
Abbreviation: CI, confidence interval.
TABLE 6 Final multivariable logistic regression model for risk factors associated with classification as epilepsy by primary-care practitioners
among cats diagnosed with recurrent seizure disorders (RSDs) under primary veterinary care in the UK
Variable Category Odds ratio 95% CI Category P-value Variable P-value
Age category (years) <3.0 Base .005
3.0-<6.0 3.32 1.66-6.67 .001
6.0-<9.0 1.53 0.74-3.18 .2
9.0-<12.0 1.38 0.65-2.91 .4
12.0-<15.0 0.61 0.26-1.45 .3
≥15.0 0.61 0.28-1.45 .3
Unrecorded 4.72 0.87-25.41 .1
Insurance Noninsured Base <.001
Insured 1.88 0.91-3.90 .1
Unrecorded 0.77 0.40-1.47 .42
Notes: N = 458.
Abbreviation: CI, confidence interval.
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compared with cats aged <3.0 years. Insurance was retained as a
confounder in the final model (Table 6).
4 | DISCUSSION
Ours is the first study to explore RSD and epilepsy in cats by analyzing
data from a multicenter primary care research database in the UK.
Our study of 285 547 cats attending UK primary care practices in
2013 reports a 1-year period prevalence of 0.16% for RSD and 0.04%
for epilepsy as classified by primary care veterinary practitioners.
These results confirm that although RSD are less frequently diagnosed
in cats than in dogs,7,8,37 RSD are a relatively common clinical presen-
tation for cats evaluated by veterinary practitioners, which is consis-
tent with previous reports.38,39 Numerically, despite the relatively low
prevalence of these disorders, an estimated 10.9 million cats are
owned in the UK with 24% of UK adults owning a cat,40 which equa-
tes to a substantial number of potentially affected cats in the UK. Our
findings are substantially lower than the 2.1% and 3.5% prevalences
of seizures previously reported in referral feline populations.3,4 This
difference likely reflects inherent differences in caseloads between
primary care and referral practices,6 and mirrors a discrepancy
described in Germany where the primary care period prevalence of
dogs presenting with seizures was 0.43% compared to 1.78% in a
referral population.41 Considering the differences between cats and
dogs, although the prevalence for RSD in cats is considerably lower
than the prevalence in dogs with at least 1 seizure reported previ-
ously,8 the inclusion criteria for RSD in our study required cats to have
had at least 2 seizure events separated by at least 24 hours, an epi-
lepsy diagnosis, or treatment using ASD. Given that toxicity and meta-
bolic disturbances (reactive seizures) are responsible for many single
seizure events,3,38,39 this situation may account for a proportion of
the differences reported between the species. Additionally, recogni-
tion of seizures in cats often is complicated by the heterogenous
semiology of the condition in this species,4,13,42,43 such that the true
proportion of cats with RSD may be higher than that reported by
owners. Furthermore, compared to dogs, many UK cats spend a con-
siderable proportion of their time outdoors, where owners are less
likely to witness seizure events.39
Despite substantial progress in recent decades on the classifica-
tion of neurological diseases in companion animals5 along with efforts
to formally define internationally-accepted diagnostic lexicons and
definitions,19 reluctance remains for primary care practitioners to
evaluate and identify their neurological clinical caseloads.44 This reluc-
tance for standardized diagnosis recording means that many primary
care cases are recorded using phenotypic signature (ie, seizure disor-
der) rather than a formal diagnosis term (eg, epilepsy). This phenome-
non was highlighted in a recent study of seizure disorders in dogs
presenting to primary care clinics where only 10.7% of idiopathic epi-
lepsy cases that met IVETF criteria were recorded as epilepsy or idio-
pathic epilepsy in the clinical records.45 One impact for scientific
research arising from this tendency toward informal diagnosis record-
ing is that studies that rely on formally-recorded diagnosis terms are
likely to substantially underreport the true frequency of these disor-
ders. Consequently, and in an effort to include all true cases in our
study, we chose not to rely on formal diagnosis terms such as epilepsy
or idiopathic epilepsy as recorded in the clinical notes but instead to
focus more on a phenotypic signature that would identify cats
with RSD.
A formal diagnosis of epilepsy was recorded by the first opinion
veterinary practitioner for 114 (24.89%) of the 458 RSD cases,
although it is likely that many more of these cases met the
internationally-agreed definition for epilepsy despite not being
recorded as such by the attending veterinarians.19 The precise clinical
criteria applied for the epilepsy diagnoses recorded in the clinical
records was not explored in our study, but these could be the topic of
future research exploring how closely primary care clinicians apply
IVETF diagnosis guidelines.44 It is likely that a final pathophysiological
rationale for the disorder was not reached in many of the cases that
were not recorded as epilepsy, and therefore the attending veterinar-
ians recorded the condition based on its phenotypic signature rather
than spuriously recording a biomedical diagnosis term that they could
not be confident was correct. Our study applied the diagnosis term
“epilepsy” to include subclassifications including idiopathic and struc-
tural epilepsy as well as epilepsy of unknown cause.19
Diagnosis of “epilepsy” in veterinary medicine classically requires
≥2 seizures that are 24 hours apart and cases without a known under-
lying cause generally are recorded as “idiopathic epilepsy.”46 As with
all idiopathic conditions, idiopathic epilepsy is a diagnosis of exclusion,
and therefore relies on the clinical acumen and resources available to
the relevant veterinary teams.47 In dogs aged 6 months to 6 years
with normal interictal neurological examination, lack of clinically rele-
vant abnormalities on routine blood serum biochemical and urinalysis
tests with typical seizure presentation is consistent with Tier I level of
diagnostic confidence.44 A similar consensus view on diagnostic confi-
dence for cats currently is not available. In cats, idiopathic epilepsy
historically has been considered relatively rare, but in recent years
more investigators have used the term routinely for cats and reported
that up to 57% of cats with epilepsy might be classified as having idio-
pathic epilepsy.13 It is conceivable that general veterinary practi-
tioners may feel reluctant to formally diagnose epilepsy or idiopathic
epilepsy in cats because of a combination of factors, including their
limited confidence in performing a complete neurological examination
in cats, the longstanding traditional belief that cats do not commonly
have idiopathic epilepsy, and a belief that access to advanced imaging
is essential to exclude other causes. Epilepsy was discussed as a possi-
ble diagnosis in a further 69 cats in our study, which could increase
the proportion of RSD cases with a diagnosis of epilepsy to 183/458
cats (39.95%), although this figure could be substantially lower
because cats >7 years of age are more likely to have structural epi-
lepsy.43 Cats with RSD cats that have a normal interictal neurological
examination not infrequently are identified as having structural epi-
lepsy based on advanced imaging, with 12.2% having clinically rele-
vant magnetic resonance imaging (MRI) abnormalities reported in 1
study.48 This proportion is similar to the 11.8% of clinically relevant
MRI findings reported in dogs with normal interictal neurological
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examinations.49 Thus, it is likely that some cats diagnosed with epi-
lepsy in our study may have had an unrecognized structural cause that
advanced imaging would have elucidated.
The median age at first recorded seizure event for RSD overall in
our study was 8.9 years, which was comparatively higher than the
median age of 6.4 years at first recorded seizure event for the subset
of cats with RSD that we recorded as having epilepsy. Results of the
risk factor modeling highlight the age group that is most likely to be
diagnosed with epilepsy from among the RSD caseloads: cats aged
3 to 6 years had 3.32 times the odds of diagnosis compared with cats
aged <3 years old. This tendency to diagnose epilepsy in younger cats
among RSD caseloads is consistent with most previous studies, which
reported cats diagnosed with epilepsy as younger than cats with
structural causes. The reported ages of 3.4 to 4.6 years for epilepsy
are lower than the 8.1 to 9.2 years reported for cats with structural
causes.3,4,20,43,48,50 Compared with cats <3 years of age, the odds of a
diagnosis of epilepsy was higher in all older age groups (except for
cats aged 12-15 years). Therefore, although 3 to 6 years may be the
peak time at which most cases of idiopathic epilepsy in cats are diag-
nosed, this condition should not be excluded for diagnosis in older
animals simply because of their age. However, the odds of diagnosis
of epilepsy in both the overall population and among the RSD case-
loads suggest that cats <3 years of age have lower odds of diagnosis
with epilepsy. These findings for the age at which epilepsy is most
likely to affect cats can serve as a benchmark for practitioners when
prioritizing differential causes of RSD in cats. Furthermore, this infor-
mation may assist in the future development of guidelines in cats for
the classification and diagnosis of idiopathic epilepsy.
Although the odds of diagnosis specifically with epilepsy were
highest in cats aged 3 to 6 years, the odds of diagnosis with RSD in
general increased progressively with age. Structural causes of RSD are
reported in 40% to 70% of affected cats.13 The RSD caseload in our
study likely includes several underlying conditions, including neoplas-
tic and vascular disorders that predominantly affect older animals.9,43
Additionally, although recognized cases of reactive seizures were
excluded from our study, some may have remained given that not all
cases were comprehensively evaluated by complete serum biochemis-
try, urinalysis and blood pressure measurement. Because reactive sei-
zures are also predominantly caused by conditions that preferentially
affect older animals,39 potential retention of some misclassified reac-
tive seizure cases in our study may have increased the apparent prob-
ability of RSD in older cats. Seizures therefore should be considered
as a common cause of paroxysmal events in cats, particularly with
increasing age. This information may offer primary practitioners evi-
dence with which to advise medical and possibly advanced imaging
studies in cases in which seizures are suspected.
Insured cats had 1.49 times the odds of diagnosis with RSD com-
pared with uninsured cats in our study. Animals that are insured are
more likely to be presented to veterinary practices for investigation of
medical problems because financial barriers to presentation are
decreased.51 Although it is also possible that a small proportion of cats
may have become insured because their owners suspected a health
problem, it is more likely that the higher diagnosis rates in insured cats
reflect greater awareness of disease in insured cats rather than truly
higher rates of inherent disease. The association between insurance
and diagnosis was even higher for epilepsy, with insured cats showing
2.38 times the odds of a diagnosis of epilepsy compared with
uninsured cats. Similar associations with increased diagnosis in
insured animals have been reported previously for several disorders
including diabetes mellitus in cats (×2.0),52 lipoma in dogs (×1.78),53
hyperadrenocorticism in dogs (×4.0),54 and corneal ulceration in dogs
(×1.6).55 This insurance bias must be considered carefully when gener-
alizing the results of studies that are based entirely on data from
insured animals.37 We did not report the proportion of animals
referred for specialist management or that underwent advanced imag-
ing, but it would have been useful to know these because a normal
brain MRI and cerebrospinal fluid (CSF) analysis would increase confi-
dence in a diagnosis of idiopathic epilepsy and insured animals are
more likely to undergo this level of diagnostic evaluation.
Our findings do not support an association between breed and RSD
in cats. The prevalence of RSD was not statistically different between
crossbred cats (0.17%) and purebred cats (0.13%, P = .16). Breeds in our
study with the highest RSD prevalence were Foreign (breed prevalence,
1.89%) and Burmilla (0.84%), but these results should be interpreted
with caution because only 1 affected individual was represented in each
of these breeds. The relatively low proportion of individual purebred cat
breeds in the UK means that our study was grossly underpowered to
evaluate breed as a risk factor. Given that the demographic data
reported in our study show that crossbred cats comprise the majority of
the UK pet cat population, this factor will always make it challenging to
achieve good statistical power for breed comparisons in cats, even with
access to increasingly large research datasets over time.25-27 However,
ownership of purebred cats currently is increasing, which may facilitate
breed-based research in cats in the future.56
Specifically in relation to epilepsy, the results of univariable analy-
sis in our study indicated that Burmese, Birman, and British Short Hair
cats to have 3.27, 2.14, and 1.85 times the odds, respectively, of epi-
lepsy compared to crossbreed cats, but the breed variable was not
retained on multivariable analysis. The low counts of affected animals
of these breeds in our study precludes firm conclusions from being
drawn about breed risk, but these breeds perhaps should be consid-
ered specifically in future explorations of genetic factors for epilepsy
of cats. A previous referral study in the UK reported that pedigreed
cats had 5.68 times the odds of epilepsy compared with nonpedigreed
cats.43 However, unlike the situation in dogs, specific breeds have not
yet been linked to epilepsy in cats, and genetic epilepsy only has been
reported in study colonies of cats.11,17,18 A study of audiogenic reflex
seizures in cats reported that a large number of affected cats were
Birmans.57 Audiogenic reflex seizures are proposed to have a genetic
basis despite their geriatric onset and possibly represent a genetic
type of epilepsy in cats.57 Further investigation of genetic causes of
epilepsy in cats would benefit from similar development of rigorous
diagnostic criteria of epilepsy of unknown cause in cats, as has been
achieved in dogs.5,19
No evidence was found of an association between sex and either
RSD or epilepsy in cats in our study. This finding is consistent with
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previous studies in cats.3,4 In dogs, males may have increased odds of
developing seizure disorders,7,8,58 but this observation is complicated
by effects of neutering as well as different sex predisposition to sei-
zures among specific dog breeds.58,59
Despite the large numbers of cats affected by RSD in our study, no
antiseizure medications currently are licensed for use in cats in the UK.
Several studies have shown that cats can respond well to medical treat-
ment and furthermore that stopping treatment leads to recurrence of
seizure activity in up to 75% of affected cats.13,60 Our findings should
prompt manufacturers to consider steps to undertake the licensing of
antiseizure medications in cats and encourage practitioners to consider
medical treatment of affected animals.
Our study had some limitations. Despite there being an estimated
1 million more owned cats than dogs in the UK,40 far fewer cats are
registered at veterinary practices than dogs.26,61 Although our study
aimed to provide reliable estimates for the prevalence and demo-
graphics of RSD-affected cats, many owned cats are not under routine
veterinary care and thus our results should be interpreted with cau-
tion and not generalized. Barriers to regular veterinary presentation of
cats may include lower numbers of insured cats than dogs (ie, 7% vs
19% of animals attending VetCompass participating practices) and
perceived difficulties in medicating cats. Diagnosis of epilepsy in our
study relied on the opinion of the primary care practitioner rather
than the formal classification guidelines as laid out by IVETF, which
were published after data collection for our study.5,19
Only fair to moderate interobserver agreement has been found
between neurologists and nonspecialists when diagnosing seizure
activity in dogs and cats15 and, as discussed above, poor concordance
has been shown between primary care and retrospective classification
of epilepsy cases in dogs.45 Improvement in future studies using simi-
lar datasets would include extraction of information pertaining to
ancillary testing so as to categorize animals into an IVEFT Tier 1 level
of confidence of diagnosis of epilepsy. In addition to the clinical acu-
men of the individual veterinary practitioner and the available diag-
nostic tests, an accurate description of events by owners is also
essential to generate the initial index of suspicion of seizure activity,62
but such ability is likely to vary substantially among owners.
5 | CONCLUSION
Our large retrospective study using a multicenter primary practice
dataset found a 0.16% prevalence of RSD in cats, highlighting that
these disorders are not uncommon in this species. Recurrent seizure
disorders increase in prevalence with increasing age. No evidence was
found for sex and breed associations with RSD in cats, which may
reflect multiple etiologies in this species. Epilepsy was recorded in
0.04% of cats by primary care practitioners, with cats aged 3 to
6 years being the most likely age group of cats with RSD to be diag-
nosed with epilepsy. Future studies using expanded datasets are
needed to fully explore questions related to semiology and clinical
outcomes. The veterinary neurology community should take efforts to
better define the term “epilepsy” in cats and develop diagnostic
criteria.
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